Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor January 9, 2020
Kyruus Raises $42 Million in New Financing After Delivering Another Year of Record Growth January 8, 2020
Apellis Pharmaceuticals’ drug candidate outperforms Alexion’s Soliris in a clinical trial comparing the two January 7, 2020
Sirnaomics and Innovent Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining STP705 and Sintilimab in the US January 7, 2020
Firefly Health and PhysicianOne Urgent Care Announce Partnership, Building a Value-Based Clinical Network for Exceptional Patient Care December 19, 2019
Turnstone Biologics Announces Global Collaboration and License Agreement with Takeda to Develop Novel Viral Immunotherapies December 19, 2019
Vynca and PatientPing Announce Partnership to Integrate Advance Care Plans Into Real-Time Care Collaboration Platform December 17, 2019